连云港市妇幼保健院产科超说明书用药现状分析及管理
Analysis and management of off-label drug use in obstetrics Department of Lianyungang Maternal and Child Health Hospital
高雪 1杨静 1宋和娣 1崔爱瑛1
作者信息
- 1. 连云港市妇幼保健院药学部,连云港 222006
- 折叠
摘要
为促进产科合理用药,降低孕产妇用药风险,现抽取连云港市妇幼保健院产科2021年1～6月门诊处方8733张和住院病历4812份,超说明书用药点评和循证医学证据评价结果显示:门诊处方超说明书用药1074张(12.30％),其中不合理处方89张(8.29％);住院病历超说明书用药2993份(62.20％),其中不合理898份(30.00％);超说明书用药药品有20种,其中16种有循证医学证据支持.制定并实施《超说明书用药管理规定及程序》和超说明书用药备案审核流程后,对2022年1～6月的门诊处方和住院病历进行点评,结果显示超说明书用药不合理比例均下降,分别为2.51％(31/1235)和 9.03％(182/2016).
Abstract
In order to promote rational medication in obstetrics and reduce medication risks for preg-nant and postpartum women,8733 outpatient prescriptions and 4812 inpatient medical records were select-ed from the Obstetrics Department of Lianyungang Maternal and Child Health Hospital from January to June 2021.The results of review on off-label drug use and evidence-based medicine evaluation showed that 1074 outpatient prescriptions were off-label drug use(12.30％),including 89 unreasonable prescriptions(8.29％);2993 cases(62.20％)of inpatient medical records were off-label drug use,of which 898 cases(30.00％)were unreasonable;There were 20 types of drugs that were off-label drug use,of which 16 were supported by evidence-based medicine.After the formulation and implementation of the"Regulations and Procedures for the Management of Off-label Drug Use"and the review process for off-label drug use,the re-evaluation results from January to June 2022 showed that the unreasonable proportion of outpatient pre-scriptions and inpatient medical records for off-label drug use decreased to 2.51％(31/1235)and 9.03％(182/2016),respectively.
关键词
产科/超说明书用药/管理策略Key words
Obstetrics/Off-label drug use/Management strategy引用本文复制引用
基金项目
江苏省药学会-奥赛康医院药学科研项目(A202147)
出版年
2024
NETL
NSTL
万方数据